In fusion‐positive rhabdomyosarcoma (FP‐RMS), high levels of FGFR4 expression are transcriptionally driven by the protein product of the recurrent fusion gene PAX3‐FOXO1 [16, 17]. The gene discussed is FGFR4; the disease is rhabdomyosarcoma.